FGF-2 and anosmin-1 are selectively expressed in different types of multiple sclerosis lesions

Journal of Neuroscience

Volumn 31, Issue 42, 2011, Pages 14899-14909

  Clemente, Diego ^a   Ortega, María Cristina ^a   Arenzana, Francisco Javier ^a   de Castro, Fernando ^a,b  

^a HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANOSMIN 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPSY; BLOOD BRAIN BARRIER; CELL MIGRATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROGLIA; MOLECULAR BIOLOGY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL; UPREGULATION;

ADULT; ADULT STEM CELLS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; CEREBRAL CORTEX; CRICETINAE; CRICETULUS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GANGLIOSIDES; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA-DR ANTIGENS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PHOSPHOPROTEINS; POSTMORTEM CHANGES; PROTEOGLYCANS; PYRROLES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TRANSFECTION; UP-REGULATION;

EID: 80054774307     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1158-11.2011     Document Type: Article

References (67)

1. Araujo DM, Cotman CW (1992) Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 12:1668-1678.
2. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC (2002) Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574-8585.
3. Armstrong RC, Le TQ, Flint NC, Vana AC, Zhou YX (2006) Endogenous cell repair of chronic demyelination. J Neuropathol Exp Neurol 65:245-256.
4. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
5. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966-972.
6. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE (1996) Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7:263-275.
7. Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J (2007) Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27:2396-2402.
8. Bögler O, Wren D, Barnett SC, Land H, Noble M (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A 87:6368-6372.
9. Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16-25.
10. Bribián A, Barallobre MJ, Soussi-Yanicostas N, de Castro F (2006) Anosmin-1 modulates the FGF-2-dependent migration of oligodendrocyte precursors in the developing optic nerve. Mol Cell Neurosci 33:2-14.
11. Bribián A, Esteban PF, Clemente D, Soussi-Yanicostas N, Thomas JL, Zalc B, de Castro F (2008) A novel role for anosmin-1 in the adhesion and migration of oligodendrocyte precursors. Dev Neurobiol 68:1503-1516.
12. Butt AM, Dinsdale J (2005) Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo. Exp Neurol 192:125-133.
13. Capello E, Voskuhl RR, McFarland HF, Raine CS (1997) Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination. Ann Neurol 41:797-805.
14. Cariboni A, Pimpinelli F, Colamarino S, Zaninetti R, Piccolella M, Rumio C, Piva F, Rugarli EI, Maggi R (2004) The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropinreleasing hormone (GnRH)-producing neurons. Hum Mol Genet 13:2781-2791.
15. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
16. Chang A, Smith MC, Yin X, Fox RJ, Staugaitis SM, Trapp BD (2008) Neurogenesis in the chronic lesions of multiple sclerosis. Brain 131:2366-2375.
17. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C (2002) Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 125:1972-1979.
18. Claudio L, Raine CS, Brosnan CF (1995) Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 90:228-238.
19. Clemente D, Esteban PF, del Valle I, Bribián A, Soussi-Yanicostas N, Silva A, de Castro F (2008) Expression pattern of Anosmin-1 during pre-and postnatal rat brain development. Dev Dyn 237:2518-2528.
20. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502-1517.
21. de Castro F, Bribián A (2005) The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev 49:227-241.
22. Dellovade TL, Hardelin JP, Soussi-Yanicostas N, Pfaff DW, Schwanzel-Fukuda M, Petit C (2003) Anosmin-1 immunoreactivity during embryogenesis in a primitive eutherian mammal. Brain Res Dev Brain Res 140:157-167.
23. Diemel LT, Copelman CA, Cuzner ML (1998) Macrophages in CNS remyelination: friend or foe? Neurochem Res 23:341-347.
24. Dietrich JB (2002) The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J Neuroimmunol 128:58-68.
25. Docagne F, Muñetón V, Clemente D, Ali C, Loría F, Correa F, Hernango ́mez M, Mestre L, Vivien D, Guaza C (2007) Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol Cell Neurosci 34:551-561.
26. Duke VM, Winyard PJ, Thorogood P, Soothill P, Bouloux PM, Woolf AS (1995) KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 110:73-79.
27. Farmer SF, Harrison LM, Mayston MJ, Parekh A, James LM, Stephens JA (2004) Abnormal cortex-muscle interactions in subjects with X-linked Kallmann's syndrome and mirror movements. Brain 127:385-397.
28. Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 354:942-955.
29. García-González D, Clemente D, Coelho M, Esteban PF, Soussi-Yanicostas N, de Castro F (2010) Dynamic roles of FGF-2 and Anosmin-1 in the migration of neuronal precursors from the subventricular zone during pre-and postnatal development. Exp Neurol 222:285-295.
30. Goddard DR, Berry M, Butt AM (1999) In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J Neurosci Res 57:74-85.
31. Goddard DR, Berry M, Kirvell SL, Butt AM (2001) Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol Cell Neurosci 18:557-569.
32. Henderson AP, Barnett MH, Parratt JD, Prineas JW (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66:739-753.
33. Jakovcevski I, Mo Z, Zecevic N (2007) Down-regulation of the axonal polysialic acid-neural cell adhesion molecule expression coincides with the onset of myelination in the human fetal forebrain. Neuroscience 149:328-337.
34. Kinter J, Allaman I, Schroeder K, Tschopp J, Magistretti P, Schaeren-Wiemers N (2009) Cellular immunity and pathological alterations in MS grey matter. Glia 57:S92.
35. Kirk J, Plumb J, Mirakhur M, McQuaid S (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201:319-327.
36. Koning N, Bö L, Hoek RM, Huitinga I (2007) Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62:504-514.
37. Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJ (2001) Macrophage depletion impairs oligodendrocyte remyelination following lysolecithininduced demyelination. Glia 35:204-212.
38. Krams M, Quinton R, Mayston MJ, Harrison LM, Dolan RJ, Bouloux PM, Stephens JA, Frackowiak RS, Passingham RE (1997) Mirror movements in X-linked Kallmann's syndrome. II. A PET study. Brain 120:1217-1228.
39. Langford D, Hurford R, Hashimoto M, Digicaylioglu M, Masliah E (2005) Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. BMC Neurosci 6:8.
40. Liu X, Mashour GA, Webster HF, Kurtz A (1998) Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin. Glia 24:390-397.
41. Lutz B, Kuratani S, Rugarli EI, Wawersik S, Wong C, Bieber FR, Ballabio A, Eichele G (1994) Expression of the Kallmann syndrome gene in human fetal brain and in the manipulated chick embryo. Hum Mol Genet 3:1717-1723.
42. Martínez-Forero I, Peláez A, Villoslada P (2008) Pharmacogenomics of multiple sclerosis: in search for a personalized therapy. Expert Opin Pharmacother 9:3053-3067.
43. Mayston MJ, Harrison LM, Quinton R, Stephens JA, Krams M, Bouloux PM (1997) Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study. Brain 120:1199-1216.
44. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
45. Merchán P, Bribián A, Sánchez-Camacho C, Lezameta M, Bovolenta P, de Castro F (2007) Sonic hedgehog promotes the migration and proliferation of optic nerve oligodendrocyte precursors. Mol Cell Neurosci 36:355-368.
46. Murcia-Belmonte V, Esteban PF, García-González D, de Castro F (2010) Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix. J Neurochem 115:1256-1265.
47. Nakajima K, Tohyama Y, Maeda S, Kohsaka S, Kurihara T (2007) Neuronal regulation by which microglia enhance the production of neurotrophic factors for GABAergic, catecholaminergic, and cholinergic neurons. Neurochem Int 50:807-820.
48. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952.
49. Omari KM, John GR, Sealfon SC, Raine CS (2005) CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128:1003-1015.
50. Padden M, Leech S, Craig B, Kirk J, Brankin B, McQuaid S (2007) Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol 113:177-186.
51. Reuss B, Dono R, Unsicker K (2003) Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J Neurosci 23:6404-6412.
52. Rottlaender A, Villwock H, Addicks K, Kuerten S (2011) Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis. Immunology 133:370-378.
53. Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A, Desina G, Glorioso JC, Comi G, Martino G (2001) Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther 8:1207-1213.
54. Sarchielli P, Di Filippo M, Ercolani MV, Chiasserini D, Mattioni A, Bonucci M, Tenaglia S, Eusebi P, Calabresi P (2008) Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 435:223-228.
55. Schnell SA, Staines WA, Wessendorf MW (1999) Reduction of lipofuscinlike autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 47:719-730.
56. Sobue K, Yamamoto N, Yoneda K, Hodgson ME, Yamashiro K, Tsuruoka N, Tsuda T, Katsuya H, Miura Y, Asai K, Kato T (1999) Induction of bloodbrain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res 35:155-164.
57. Soussi-Yanicostas N, Hardelin JP, Arroyo-Jimenez MM, Ardouin O, Legouis R, Levilliers J, Traincard F, Betton JM, Cabanie ́ L, Petit C (1996) Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci 109:1749-1757.
58. Soussi-Yanicostas N, de Castro F, Julliard AK, Perfettini I, Chédotal A, Petit C (2002) Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 109:217-228.
59. Steinman L (2005) Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nat Rev Drug Discov 4:510-518.
60. Su JJ, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, Mihara F, Taniwaki T, Kira J (2006) Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 243:21-30.
61. Tengara S, Tominaga M, Kamo A, Taneda K, Negi O, Ogawa H, Takamori K (2010) Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis. J Dermatol Sci 58:64-71.
62. Trapp BD, Bö L, Mörk S, Chang A (1999) Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98:49-56.
63. Wang Y, Imitola J, Rasmussen S, O'Connor KC, Khoury SJ (2008) Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog-Gli1 in autoimmune encephalomyelitis and multiple sclerosis. Ann Neurol 64:417-427.
64. Williams A, Piaton G, Aigrot MS, Belhadi A, Théaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C (2007) Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130:2554-2565.
65. Yin J, Sakamoto K, Zhang H, Ito Z, Imagama S, Kishida S, Natori T, Sawada M, Matsuyama Y, Kadomatsu K (2009) Transforming growth factorbeta1 upregulates keratan sulfate and chondroitin sulfate biosynthesis in microglias after brain injury. Brain Res 1263:10-22.
66. Young EA, Fowler CD, Kidd GJ, Chang A, Rudick R, Fisher E, Trapp BD (2008) Imaging correlates of decreased axonal Na_/K_ ATPase in chronic multiple sclerosis lesions. Ann Neurol 63:428-435.
67. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T (1998) Fibroblast growth factor 2 control of vascular tone. Nat Med 4:201-207.